PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Becton, Dickinson and Company

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

New Collaboration Aims to Improve Access to TB Diagnostics - BD and FIND extend pricing agreement to reach HIV-Positive patients in India (NYSE: BDX) -
New Collaboration Aims to Improve Access to TB Diagnostics


NewswireToday - /newswire/ - Franklin Lakes, NJ, United States, 2012/03/27 - BD and FIND extend pricing agreement to reach HIV-Positive patients in India (NYSE: BDX) - NYSE: BDX

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


BD (Becton, Dickinson and Company) and FIND (Foundation for Innovative New Diagnostics) have announced a new collaboration to promote access to early and accurate diagnosis of multidrug-resistant tuberculosis (MDR-TB) among HIV-infected patients and other vulnerable populations in India, a country that accounts for nearly 25 percent of TB cases globally.

The 18-month program will focus on increasing the number of accurately diagnosed TB patients in the northern region of India’s Karnataka state. The BD-FIND collaboration will help to increase access to state-of-the-art diagnostics by extending an existing pricing agreement, which significantly reduces the price of the BD BACTEC™ MGIT™ system. The initiative, in partnership with Kasturba Medical College (KMC), also seeks to establish a new collaboration model in which a private hospital provides critical medical services to public patients.

“TB is a dangerous disease, and it requires an all-hands-on-deck effort to control it and prevent the rise of drug resistance,” said Tom Polen, President, BD Diagnostics – Diagnostic Systems. “Through our collaboration with FIND and KMC, we’re helping to do that by ensuring that more people in India will get tested quickly and accurately, and treated appropriately from the beginning.”

“The first step to treatment is having an accurate diagnosis,” said Philippe Jacon, Chief Executive Officer, FIND. “It is widely acknowledged that affordability, privacy, social stigma, easy access and rapid turnaround time make the private sector a primary choice for nearly 40 percent of Indian patients. Our latest agreement with BD will give a highly disease-threatened community in India access to the technologies and health programs needed for a healthier life.” Jacon attended the signing ceremony for the BD-FIND partnership in India, along with Gary Cohen, Executive Vice President, BD.

Helping KMC become an accredited center for performing culture and drug-susceptibility testing, BD will facilitate laboratory staff training at KMC through September 2013, offer BD-FIND negotiated pricing on equipment, and provide technical expertise. The partnership will also facilitate the transportation of samples to enable rapid processing and diagnosis at KMC. Positive TB results will be sent without delay to district hospitals, helping ensure that MDR- and extremely drug-resistant TB (XDR-TB) patients receive timely follow-up treatment. The program will also help track patient adherence to recommended treatment protocols.

According to the WHO, an estimated 99,000 MDR-TB cases were reported in India in 2008. USAID reports that Northern Karnataka has one of India’s largest HIV burdens and, as noted by UNAIDS, HIV-TB co-infection is one of the leading causes of death for a person with HIV.

India currently implements the Revised National TB Control Program (RNTCP) through the public health system to promote access to technologies and strengthen healthcare systems. However, with delays in the establishment and accreditation of laboratories through this program, limited testing facilities, and inadequately trained laboratory personnel, properly diagnosing and detecting strains of TB has become increasingly difficult.

About FIND
The Foundation for Innovative New Diagnostics is dedicated to developing affordable, easy-to-use and cutting edge diagnostic tests that save lives in the poorest areas of the world. From the initial idea and discovery stage to putting new tests into practice, the organization works with multiple and diverse groups, such as academia, industry, donors, partners in the field, Ministries of Health and the World Health Organization. With five new diagnostic tools for TB already in use, FIND also has established programmes in malaria and sleeping sickness, and has begun working on other neglected diseases, such as leishmaniasis and Chagas. Launched in 2003, the not-for-profit Foundation is ISO certified and financed by both the private and public sectors, including the Bill & Melinda Gates Foundation, Government of the Netherlands, European Union, UNITAID, UK Department for International Development, National Institutes of Health (USA), UBS Optimus Foundation and others.

About BD
BD ( is a leading medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people’s health through the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Written by / Agency / Source: Becton, Dickinson and Company


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick Newswire Today Visibility Checker


Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

# # #

  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!

New Collaboration Aims to Improve Access to TB Diagnostics

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

BD |
Publisher Contact: Alyssa Zeff - 
201-847-4358 alyssa_zeff[.]
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Becton, Dickinson and Company securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From Becton, Dickinson and Company / Company Profile

Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business


Visit  SKS Media | SKS Associates Ltd


  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (